Advanced Characterization of Semaglutideand Its Impurities Using a Heart-Cutting 2D-LC/MS Workflow for Biopharmaceutical Analysis

Poster Reprint ASMS 2026 MP 536 Comprehensive characterization of oligonucleotides and related impurities using advanced LC/Q-TOF analytical workflows Saikat Banerjee, Preeti Bharatiya, Ashish Pargaonkar, Vivek Dhyani; Agilent technologies, India Introduction Therapeutic oligonucleotides are synthetic, short nucleic acid sequences designed to…

Application Note Biopharma/Pharma Advanced 2D-LC/MS Workflow for the Characterization of Semaglutide and Its Impurities Using an Agilent 1290 Infinity III bio 2D-LC and an Agilent 6545XT AdvanceBio LC/Q-TOF Authors Abstract Paramjeet Khandpur, Preeti Bharatiya, and Ashish Pargaonkar Agilent Technologies, Inc.…

Biopharma Compendium Accelerate Your CQA Efficiency and Approach it with Multi-Attribute Methodology Breakthroughs to Increase the Efficiency of Critical Quality Attribute (CQA) Testing and Allow for a Multi- Attribute Method (MAM) Production of therapeutic monoclonal antibodies (mAbs) relies on living…

Workflow Solutions for Peptide Therapeutics Application Compendium Table of Contents Introduction4 An emerging class of peptide therapeutics: GLP-15 Analytical advances in peptide therapeutics5 Key analyses for synthetic and recombinant peptide therapeutics 6 Types of impurities in peptide therapeutics 7 Agilent…